{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:06:04Z","timestamp":1792623964405,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1124\/mol.116.106617","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T22:40:38Z","timestamp":1481236838000},"page":"110-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"title":["Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway"],"prefix":"10.1016","volume":"91","author":[{"given":"Runbin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Aa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin D.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung S.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiye","family":"Aa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.116.106617_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Abu-Shanab","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1124\/mol.116.106617_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","article-title":"GI epidemiology: nonalcoholic fatty liver disease","volume":"25","author":"Angulo","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/mol.116.106617_bib3","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1128\/AEM.72.3.1729-1738.2006","article-title":"Bile salt hydrolase activity in probiotics","volume":"72","author":"Begley","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"10.1124\/mol.116.106617_bib4","doi-asserted-by":"crossref","unstructured":"Bieghs V, Wouters K, Van Gorp PJ, Gijbels MJ, De Winther MP, Binder CJ, L\u00fctjohann D, Febbraio M, Moore KJ, Van Bilsen M (2010) Role of scavenger receptor A and Cd36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology 138: 2477\u20132486.","DOI":"10.1053\/j.gastro.2010.02.051"},{"key":"10.1124\/mol.116.106617_bib5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1194\/jlr.M600020-JLR200","article-title":"Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine","volume":"47","author":"Brusq","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.116.106617_bib6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s11306-013-0517-x","article-title":"Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells","volume":"9","author":"Cao","year":"2013","journal-title":"Metabolomics"},{"key":"10.1124\/mol.116.106617_bib7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s11745-998-0305-8","article-title":"Obesity as a risk factor for certain types of cancer","volume":"33","author":"Carroll","year":"1998","journal-title":"Lipids"},{"key":"10.1124\/mol.116.106617_bib8","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1194\/jlr.M001958","article-title":"Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats","volume":"51","author":"Chang","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.116.106617_bib9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.116.106617_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.numecd.2012.02.007","article-title":"Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease","volume":"22","author":"Compare","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1124\/mol.116.106617_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1079\/BJN19980030","article-title":"Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity","volume":"79","author":"De Smet","year":"1998","journal-title":"Br J Nutr"},{"key":"10.1124\/mol.116.106617_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2672.1995.tb03140.x","article-title":"Significance of bile salt hydrolytic activities of lactobacilli","volume":"79","author":"De Smet","year":"1995","journal-title":"J Appl Bacteriol"},{"key":"10.1124\/mol.116.106617_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.celrep.2014.02.032","article-title":"Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice","volume":"7","author":"Degirolamo","year":"2014","journal-title":"Cell Reports"},{"key":"10.1124\/mol.116.106617_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","article-title":"Epidemiology of non-alcoholic fatty liver disease in China","volume":"50","author":"Fan","year":"2009","journal-title":"J Hepatol"},{"key":"10.1124\/mol.116.106617_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat Med"},{"key":"10.1124\/mol.116.106617_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI14006","article-title":"Cd36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism","volume":"108","author":"Febbraio","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.116.106617_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1039\/C4MB00500G","article-title":"A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine","volume":"11","author":"Gu","year":"2015","journal-title":"Mol Biosyst"},{"key":"10.1124\/mol.116.106617_bib18","doi-asserted-by":"crossref","first-page":"22612","DOI":"10.1038\/srep22612","article-title":"Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/mol.116.106617_bib19","first-page":"1582","article-title":"Comparative study of pharmacokinetics and tissue distribution of 8-cetylberberine and berberine in rats.","volume":"49","author":"Hu","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/mol.116.106617_bib20","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study","volume":"67","author":"Hubert","year":"1983","journal-title":"Circulation"},{"key":"10.1124\/mol.116.106617_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0168-8278(98)80073-1","article-title":"Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance","volume":"29","author":"James","year":"1998","journal-title":"J Hepatol"},{"key":"10.1124\/mol.116.106617_bib22","doi-asserted-by":"crossref","first-page":"13580","DOI":"10.1073\/pnas.0804437105","article-title":"Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome","volume":"105","author":"Jones","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.116.106617_bib23","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.1323599111","article-title":"Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut","volume":"111","author":"Joyce","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.116.106617_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1478-3231.2006.01393.x","article-title":"Analysis of bile acid-induced regulation of FXR target genes in human liver slices","volume":"27","author":"Jung","year":"2007","journal-title":"Liver Int"},{"key":"10.1124\/mol.116.106617_bib25","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.116.106617_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.108.144600","article-title":"Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet","volume":"328","author":"Kong","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.116.106617_bib27","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1124\/mol.116.106617_bib28","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat Med"},{"key":"10.1124\/mol.116.106617_bib29","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1074\/jbc.275.14.10638","article-title":"Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor","volume":"275","author":"Laffitte","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.116.106617_bib30","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss","volume":"53","author":"Lavie","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/mol.116.106617_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.tibs.2006.08.002","article-title":"FXR, a multipurpose nuclear receptor","volume":"31","author":"Lee","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/mol.116.106617_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1194\/jlr.M500417-JLR200","article-title":"FXR regulates organic solute transporters \u03b1 and \u03b2 in the adrenal gland, kidney, and intestine","volume":"47","author":"Lee","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.116.106617_bib33","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat Commun"},{"key":"10.1124\/mol.116.106617_bib34","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1124\/dmd.110.033936","article-title":"Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats","volume":"38","author":"Liu","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.116.106617_bib35","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s11095-013-0986-7","article-title":"Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance","volume":"30","author":"Ma","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/mol.116.106617_bib36","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1124\/mol.116.106617_bib37","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1248\/bpb.34.1885","article-title":"Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice","volume":"34","author":"Miyata","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/mol.116.106617_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"10.1124\/mol.116.106617_bib39","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","article-title":"Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity","volume":"62","author":"Mueller","year":"2015","journal-title":"J Hepatol"},{"key":"10.1124\/mol.116.106617_bib40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-med-012510-175505","article-title":"Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes","volume":"62","author":"Musso","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1124\/mol.116.106617_bib41","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"key":"10.1124\/mol.116.106617_bib42","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1124\/mol.116.106617_bib43","first-page":"127","article-title":"The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease","volume":"13","author":"Polyzos","year":"2009","journal-title":"Hippokratia"},{"key":"10.1124\/mol.116.106617_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","article-title":"FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1\u03b1 pathway","volume":"13","author":"Potthoff","year":"2011","journal-title":"Cell Metab"},{"key":"10.1124\/mol.116.106617_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"10.1124\/mol.116.106617_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.diabet.2009.03.003","article-title":"Intestinal microflora and metabolic diseases","volume":"35","author":"Serino","year":"2009","journal-title":"Diabetes Metab"},{"key":"10.1124\/mol.116.106617_bib47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1124\/mol.116.106617_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077969","article-title":"Tissue distribution of berberine and its metabolites after oral administration in rats","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/mol.116.106617_bib49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000282091","article-title":"Bile acids as regulators of hepatic lipid and glucose metabolism","volume":"28","author":"Trauner","year":"2010","journal-title":"Dig Dis"},{"key":"10.1124\/mol.116.106617_bib50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"key":"10.1124\/mol.116.106617_bib51","first-page":"85","article-title":"Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma","volume":"4","author":"Vaughan","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1124\/mol.116.106617_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.atherosclerosis.2009.08.050","article-title":"Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters","volume":"209","author":"Wang","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1124\/mol.116.106617_bib53","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.metabol.2014.05.013","article-title":"Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption","volume":"63","author":"Wang","year":"2014","journal-title":"Metabolism"},{"key":"10.1124\/mol.116.106617_bib54","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1124\/mol.116.106617_bib55","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.1074\/jbc.M111.248203","article-title":"Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure","volume":"286","author":"Watanabe","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.116.106617_bib56","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.116.106617_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.21347","article-title":"Global challenges in liver disease","volume":"44","author":"Williams","year":"2006","journal-title":"Hepatology"},{"key":"10.1124\/mol.116.106617_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024520","article-title":"Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL\/6J mice","volume":"6","author":"Xie","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/mol.116.106617_bib59","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.3748\/wjg.v20.i39.14430","article-title":"FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation","volume":"20","author":"Yao","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1124\/mol.116.106617_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12967-015-0383-6","article-title":"Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles","volume":"13","author":"Yuan","year":"2015","journal-title":"J Transl Med"},{"key":"10.1124\/mol.116.106617_bib61","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.03.025","article-title":"Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis","volume":"51","author":"Zhang","year":"2009","journal-title":"J Hepatol"},{"key":"10.1124\/mol.116.106617_bib62","doi-asserted-by":"crossref","first-page":"14405","DOI":"10.1038\/srep14405","article-title":"Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1124\/mol.116.106617_bib63","article-title":"Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/mol.116.106617_bib64","first-page":"1","article-title":"An in vitro metabolic system of gut flora and the metabolism of ginsenoside Rg3 and cholic acid","volume":"39","author":"Zhao","year":"2013","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/mol.116.106617_bib65","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1038\/ncomms5573","article-title":"PPAR\u03b1-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis","volume":"5","author":"Zhou","year":"2014","journal-title":"Nat Commun"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24005820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24005820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.116.106617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T05:18:25Z","timestamp":1739942305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24005820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0026895X24005820"],"URL":"https:\/\/doi.org\/10.1124\/mol.116.106617","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.116.106617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}